Background: Pneumococcal pneumonia continues to be a significant global health burden, affecting both children and adults. Traditional diagnostic methods for sputum analysis remain challenging. The objective of this study was twofold: to develop a rapid and easy-to-perform assay for the identification of Streptococcus pneumoniae (Spn) directly in sputum specimens using fluorescence microscopy, and to characterize with high-resolution confocal microscopy the ultrastructure of pneumococci residing in human sputum.
Methods: We fluorescently labeled antibodies against the pneumococcal capsule (Spn-FLUO). The specificity and sensitivity of Spn-FLUO for detecting Spn was evaluated in vitro and in vivo using mouse models of carriage and disease, human nasopharyngeal specimens, and sputum from patients with pneumococcal pneumonia. Spn was confirmed in the specimens using culture and a species-specific qPCR assay. Spn strains were serotyped by Quellung. Confocal microscopy and Imaris software analysis were utilized to resolve the ultrastructure of pneumococci in human sputum.
Results: Compared with cultures and qPCR, Spn-FLUO demonstrated high sensitivity (78-96%) in nasopharyngeal samples from mice and humans. The limit of detection (LOD) in nasopharyngeal samples was ≥ 1.6 × 10⁴ GenEq/ml. The specificity in human nasopharyngeal specimens was 100%. In lung specimens from mice infected with pneumococci, Spn-FLUO reached 100% sensitivity with a LOD of ≥ 1.39 × 10⁴ GenEq/ml. In human sputum, the sensitivity for detecting Spn was 92.7% with a LOD of 3.6 × 10³ GenEq/ml. Ultrastructural studies revealed that pneumococci are expectorated as large aggregates with a median size of 1336 μm².
Conclusions: Spn-FLUO is a rapid and sensitive assay for detecting Spn in human sputum within 30 min, encompassing a range of both vaccine and non-vaccine serotypes associated with pneumococcal pneumonia. The study highlights that most pneumococci form aggregates in human sputum.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11881295 | PMC |
| http://dx.doi.org/10.1186/s41479-025-00157-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A mixed-methods pilot study of domiciliary nasal high-flow therapy for breathlessness in people with chronic obstructive pulmonary disease who do not qualify for domiciliary long-term oxygen therapy.
Ther Adv Respir Dis
March 2025
Faculty of Medicine and Health Sciences, University of Melbourne, Parkville, VIC, Australia.
Background: High-flow nasal oxygen (HFNO) therapy delivers humidified, heated air with flow rates of up to 60 L/min with oxygen entrained. HFNO has advantages over conventional oxygen therapy, including precise and reliable fraction of inspired oxygen delivery, therefore is recommended as first-line treatment for people with acute hypoxaemic respiratory failure.
Objectives: This pilot study aimed to determine the feasibility and acceptability of domiciliary nasal high flow (NHF) without entrained oxygen for people with chronic obstructive pulmonary disease (COPD) and severe breathlessness.
[Exposure to cassava, corn and soybean dust and respiratory health among artisanal millers in Lubumbashi (Democratic Republic of the Congo)].
Med Trop Sante Int
December 2024
Institut supérieur des techniques médicales de Lubumbashi (ISTM-Lubumbashi), République démocratique du Congo.
Objectives: The aim of this study was to determine the prevalence of respiratory symptoms, their determinants, and the state of respiratory function in millers exposed to cassava, maize, and soybean dust in Lubumbashi, Democratic Republic of Congo (DRC), compared with a group of unexposed workers.
Methods: A descriptive and analytical cross-sectional study was conducted in 2015 on 288 millers and 118 agents (n = 406) from a security agency (control group) in Lubumbashi, DRC. Participants were examined at their place of work.
Panton-Valentine Leukocidin in Necrotizing Pneumonia: A Case Report.
Cureus
February 2025
Department of Intensive Care Medicine, Unidade Local de Saúde Loures Odivelas, Loures, PRT.
Panton-Valentine leukocidin (PVL)-producing is a rare but clinically significant cause of community-acquired pneumonia (CAP). This toxin leads to extensive tissue destruction and severe inflammation, often progressing to necrotizing pneumonia, septic shock, and multiorgan failure, representing a challenge in medical practice due to its rapid progression and poor prognosis. We discuss a case of a 65-year-old diabetic male who developed severe CAP leading to septic shock, respiratory failure, and multiorgan dysfunction.
View Article and Find Full Text PDFProspective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) study: Rationale and trial design for testing urine lipoarabinomannan as a marker of NTM lung infection in cystic fibrosis.
PLoS One
March 2025
Department of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Background: Routine screening for nontuberculous mycobacterial (NTM) lung disease is dependent on sputum cultures. This is particularly challenging in the cystic fibrosis (CF) population due to reduced sputum production and low culture sensitivity. Biomarkers of infection that do not rely on sputum may lead to earlier diagnosis, but validation trials require a unique prospective design.
View Article and Find Full Text PDFPediatric Non-cystic Fibrosis Bronchiectasis in a Portuguese Tertiary Care Center: A Cross-Sectional Observational Study.
Cureus
February 2025
Pediatric Pulmonology Unit, Department of Pediatrics, Unidade Local de Saúde de São João, Porto, PRT.
Introduction Non-cystic fibrosis bronchiectasis (bronchiectasis) is an increasingly recognized but understudied disease in children. National data on this disease are scarce. This study aimed to describe the clinical, radiological, and microbiological characteristics of Portuguese children with bronchiectasis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!